Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-22-019238

Director bought 10,000 shares at $4.25 ($42,500)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BESHAR LUKE M Director 2022-03-14 Purchase +10,000 $4.25 $42,500 188,000 D: show line 1 in the form
Open-market purchases · 10,000 sh · avg $4.25 · $42,500
Loading xslF345X03/doc4.xml…